A. E. Müderrisoglu Et Al. , "Potential side effects of currently available pharmacotherapies in male lower urinary tract symptoms suggestive of benign prostatic hyperplasia," EXPERT OPINION ON DRUG SAFETY , vol.22, no.12, pp.1213-1224, 2023
Müderrisoglu, A. E. Et Al. 2023. Potential side effects of currently available pharmacotherapies in male lower urinary tract symptoms suggestive of benign prostatic hyperplasia. EXPERT OPINION ON DRUG SAFETY , vol.22, no.12 , 1213-1224.
Müderrisoglu, A. E., de la Rosette, J. J. M. C. H., & Michel, M. C., (2023). Potential side effects of currently available pharmacotherapies in male lower urinary tract symptoms suggestive of benign prostatic hyperplasia. EXPERT OPINION ON DRUG SAFETY , vol.22, no.12, 1213-1224.
Müderrisoglu, A., JOHAN JOSEPH MARIA CATHARINA HUBERTUS DELAROSETTE, And Martin C. Michel. "Potential side effects of currently available pharmacotherapies in male lower urinary tract symptoms suggestive of benign prostatic hyperplasia," EXPERT OPINION ON DRUG SAFETY , vol.22, no.12, 1213-1224, 2023
Müderrisoglu, A. E. Et Al. "Potential side effects of currently available pharmacotherapies in male lower urinary tract symptoms suggestive of benign prostatic hyperplasia." EXPERT OPINION ON DRUG SAFETY , vol.22, no.12, pp.1213-1224, 2023
Müderrisoglu, A. E. de la Rosette, J. J. M. C. H. And Michel, M. C. (2023) . "Potential side effects of currently available pharmacotherapies in male lower urinary tract symptoms suggestive of benign prostatic hyperplasia." EXPERT OPINION ON DRUG SAFETY , vol.22, no.12, pp.1213-1224.
@article{article, author={A. Elif Müderrisoglu Et Al. }, title={Potential side effects of currently available pharmacotherapies in male lower urinary tract symptoms suggestive of benign prostatic hyperplasia}, journal={EXPERT OPINION ON DRUG SAFETY}, year=2023, pages={1213-1224} }